Novo Nordisk (NYSE: NVO) has seen revenue soar in recent years thanks to two drugs that have helped people around the world ...

The complete response letter (CRL) specifies that the current dosage duration of aflibercept is still safe but extending the ...

Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...

A spokesperson confirmed the Danish drugmaker has asked U.S. regulators to clear an oral version of its weight loss drug ...

The FDA made two de­ci­sions on Re­gen­eron’s best-sell­ing drugs Fri­day, hand­ing down one ap­proval and one re­jec­tion.